We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$96.8B
AUM Growth
-$1.63B
Cap. Flow
-$6.28B
Cap. Flow %
-6.49%
Top 10 Hldgs %
7.41%
Holding
4,043
New
538
Increased
1,352
Reduced
1,501
Closed
517

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$735M
2
AAPL icon
Apple
AAPL
+$542M
3
MA icon
Mastercard
MA
+$523M
4
CRM icon
Salesforce
CRM
+$484M
5
PEP icon
PepsiCo
PEP
+$402M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 10.4%
3 Financials 10.22%
4 Healthcare 8.57%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMGF icon
3676
iShares Emerging Markets Equity Factor ETF
EMGF
$1.8B
-103
Closed -$5.36K
EMX
3677
DELISTED
EMX Royalty
EMX
-50,001
Closed -$126K
EPAM icon
3678
EPAM Systems
EPAM
$4.69B
-14,169
Closed -$2.51M
EPC icon
3679
Edgewell Personal Care
EPC
$1.27B
-34,761
Closed -$814K
EPP icon
3680
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
-32,505
Closed -$1.6M
EQH icon
3681
Equitable Holdings
EQH
$13.1B
-291,126
Closed -$16.3M
EQX icon
3682
Equinox Gold
EQX
$7.32B
-809,985
Closed -$4.67M
ESGR
3683
DELISTED
Enstar Group
ESGR
-201,713
Closed -$67.8M
ESPR
3684
DELISTED
Esperion Therapeutics
ESPR
-485,603
Closed -$478K
ETON icon
3685
Eton Pharmaceutcials
ETON
$1.17B
-34,557
Closed -$492K
ETSY icon
3686
Etsy
ETSY
$7.65B
-36,843
Closed -$2.2M
ETWO
3687
DELISTED
E2open Parent Holdings
ETWO
-895,465
Closed -$2.89M
EVR icon
3688
Evercore
EVR
$13.1B
-16,220
Closed -$4.38M
EVRI
3689
DELISTED
Everi Holdings
EVRI
-1,696,924
Closed -$24.2M
EWA icon
3690
iShares MSCI Australia ETF
EWA
$1.34B
-1,126
Closed -$29.6K
EWH icon
3691
iShares MSCI Hong Kong ETF
EWH
$1.22B
-927
Closed -$18.4K
EWI icon
3692
iShares MSCI Italy ETF
EWI
$911M
-41,415
Closed -$1.99M
EXP icon
3693
Eagle Materials
EXP
$6.6B
-13,967
Closed -$2.82M
EXPE icon
3694
Expedia Group
EXPE
$31.2B
-489,887
Closed -$98.4M
EZA icon
3695
iShares MSCI South Africa ETF
EZA
$525M
-12,461
Closed -$670K
FANG icon
3696
Diamondback Energy
FANG
$57.6B
-65,380
Closed -$9.3M
FARO
3697
DELISTED
Faro Technologies
FARO
-474,061
Closed -$20.8M
FBK icon
3698
FB Financial Corp
FBK
$2.95B
-315,557
Closed -$14.3M
FIP icon
3699
FTAI Infrastructure
FIP
$500M
-185,584
Closed -$1.15M
FITB
3700
Fifth Third Bancorp
FITB
$52B
-374,869
Closed -$15.4M

Similar funds

Qube Research & Technologies (QRT)'s Q3 2025 Portfolio in Review

As of Q3 2025, Qube Research & Technologies (QRT) held 4,043 positions worth $96.8B, down 1.7% from $98.4B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $6.28B in Q3 2025, closing 517 positions and reducing 1,501 holdings. Its most notable exit was Applovin, an estimated $390M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Qube Research & Technologies (QRT) opened a new position in Broadcom worth $754M.

  • Qube Research & Technologies (QRT)'s largest Q3 2025 buy was Broadcom: 2,284,316 shares worth $754M.
  • Qube Research & Technologies (QRT) added most to Microsoft in Q3 2025, an estimated $775M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $735M.
  • Qube Research & Technologies (QRT) fully exited Applovin in Q3 2025, selling an estimated $390M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.4% of its $96.8B portfolio in Q3 2025.
  • Qube Research & Technologies (QRT) opened 538 new positions and closed 517 in Q3 2025.
  • Qube Research & Technologies (QRT)'s portfolio value fell 1.7% quarter-over-quarter to $96.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.